If anything qualifies for a 2 month review, then surely it's this. They have to review an instruction manual, and the most vanilla trial in history. Agree with Beefarmer the FDA process is govt red tape at is worst. Great news and well done to management getting this done ahead of schedule.
If anything qualifies for a 2 month review, then surely it's...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.015(5.45%) |
Mkt cap ! $433.1M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.0¢ | 28.0¢ | $430.2K | 1.506M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 58000 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 490235 | 13 |
View Market Depth
| Last trade - 10.23am 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
28.5¢ |
Change
0.015 ( 2.89 %) |
||||
| Open | High | Low | Volume | ||
| 28.3¢ | 29.0¢ | 28.3¢ | 970809 | ||
| Last updated 10.43am 12/06/2024 ? | |||||
| BOT (ASX) Chart |